Cargando…

How Should the Value Attributes of Novel Antibiotics Be Considered in Reimbursement Decision Making?

Antibiotics have revolutionized the treatment of bacterial infections. However, it is widely held that there is underinvestment in antibiotics research and development relative to the socially optimal level for a number of reasons. In this article, we discuss whether existing health technology asses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morton, Alec, Colson, Abigail, Leporowski, Axel, Trett, Anna, Bhatti, Taimur, Laxminarayan, Ramanan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935770/ https://www.ncbi.nlm.nih.gov/pubmed/31910245 http://dx.doi.org/10.1177/2381468319892237

Ejemplares similares

Quantifying uncertainty about future antimicrobial resistance: Comparing structured expert judgment and statistical forecasting methods
por: Colson, Abigail R., et al.
Publicado: (2019)

Optimal subscription models to pay for antibiotics
por: Barlow, Euan, et al.
Publicado: (2022)

Drug pricing and reimbursement decision making systems in Mongolia
por: Dorj, Gereltuya, et al.
Publicado: (2017)

Quantifying uncertainty in intervention effectiveness with structured expert judgement: an application to obstetric fistula
por: Colson, Abigail R, et al.
Publicado: (2015)

Reference Case Methods for Expert Elicitation in Health Care Decision Making
por: Bojke, Laura, et al.
Publicado: (2021)

Decision-making criteria for medicine reimbursement in Slovenia: an expert panel discussion
por: Detiček, Andreja, et al.
Publicado: (2018)

Reimbursement decision-making system in Poland systematically compared to other countries
por: Mela, Aneta, et al.
Publicado: (2023)

Health and economic benefits of public financing of epilepsy treatment in India: An agent‐based simulation model
por: Megiddo, Itamar, et al.
Publicado: (2016)

Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries
por: Malinowski, Krzysztof Piotr, et al.
Publicado: (2019)

Drug pricing and reimbursement information management: processes and decision making in the global economy
por: Tsourougiannis, Dimitrios
Publicado: (2017)

Antibiotic Resistance in India: Drivers and Opportunities for Action
por: Laxminarayan, Ramanan, et al.
Publicado: (2016)

Interval-valued intuitionistic fuzzy multi-attribute group decision-making method considering risk preference of decision-makers and its application
por: Fu, Sha, et al.
Publicado: (2022)

Role of centralized review processes for making reimbursement decisions on new health technologies in Europe
por: Stafinski, Tania, et al.
Publicado: (2011)

“Budget Impact Analyses”: A Practical Policy Making Tool for Drug Reimbursement Decisions
por: Jamshidi, Hamid Reza, et al.
Publicado: (2014)

The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?
por: Lux, Michael Patrick, et al.
Publicado: (2021)

How should the ‘privilege’ in therapeutic privilege be conceived when considering the decision-making process for patients with borderline capacity?
por: Menon, Sumytra, et al.
Publicado: (2021)

Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city
por: Lewnard, Joseph A., et al.
Publicado: (2023)

The Neural Basis of Responsibility Attribution in Decision-Making
por: Li, Peng, et al.
Publicado: (2013)

Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement
por: Tse, Vicki C, et al.
Publicado: (2011)

Informed decision‐making: Statistical methodology for surrogacy evaluation and its role in licensing and reimbursement assessments
por: Weir, Christopher J., et al.
Publicado: (2022)

A Process for Evaluating Quality Decision-Making Practices During the Development, Review and Reimbursement of Medicines
por: Bujar, Magdalena, et al.
Publicado: (2020)

Should children's hospitals have special consideration in reimbursement policy?
por: Long, Michael J., et al.
Publicado: (1986)

Implementing shared decision-making: consider all the consequences
por: Elwyn, Glyn, et al.
Publicado: (2016)

Pre-reimbursement: early assessment for coverage decisions
por: Grössmann, Nicole, et al.
Publicado: (2019)

An influential node identification method considering multi-attribute decision fusion and dependency
por: Chen, Chao-Yang, et al.
Publicado: (2022)

An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries
por: Kamusheva, Maria, et al.
Publicado: (2018)

Engaging the Canadian public on reimbursement decision-making for drugs for rare diseases: a national online survey
por: Polisena, Julie, et al.
Publicado: (2017)

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies
por: Bloem, Lourens T., et al.
Publicado: (2021)

Fuzzy multiple attribute decision making: methods and applications
por: Chen, Shu-Jen, et al.
Publicado: (1992)

Sewage surveillance of antibiotic resistance holds both opportunities and challenges
por: Larsson, D. G. Joakim, et al.
Publicado: (2022)

PSA change after antibiotic treatment should not affect decision-making on performing a prostate biopsy
por: KAYALI, Yunus, et al.
Publicado: (2022)

Decision Making in Manufacturing Environment Using Graph Theory and Fuzzy Multiple Attribute Decision Making Methods
por: Rao, R Venkata
Publicado: (2013)

How do enterprises determine which breakthrough invention should be commercialized? A multiple attribute group decision-making-based method
por: Tang, Fangcheng, et al.
Publicado: (2022)

The difficulty of medical decision-making: should patients be involved?
por: Zhou, Junbin, et al.
Publicado: (2023)

New methods and applications in multiple attribute decision making (MADM)
por: Alinezhad, Alireza, et al.
Publicado: (2019)

The art of decision-making
por: Davis, Morton
Publicado: (1986)

How should hospital reimbursement be refined to support concentration of complex care services?
por: Bojke, Chris, et al.
Publicado: (2017)

Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index
por: Klein, Eili Y, et al.
Publicado: (2019)

Using multicriteria decision analysis during drug development to predict reimbursement decisions
por: Williams, Paul, et al.
Publicado: (2014)

Three-Way Decision Models Based on Ideal Relations in Multi-Attribute Decision-Making
por: Chen, Xiaozhi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7pv67cfe274qmd6a5boqbidch9